- 专利标题: BIOSYNTHETIC PRODUCTION OF PSILOCYBIN AND RELATED INTERMEDIATES IN RECOMBINANT ORGANISMS
-
申请号: US17878858申请日: 2022-08-01
-
公开(公告)号: US20220389467A1公开(公告)日: 2022-12-08
- 发明人: Jacob Michael Vogan , Laura Flatauer Peiffer , James Lee Wade , Tyrone Jacob Yacoub , Kirsten Tang , Rachel Nadine Burnett
- 申请人: CB Therapeutics, INC.
- 申请人地址: US CA Carlsbad
- 专利权人: CB Therapeutics, INC.
- 当前专利权人: CB Therapeutics, INC.
- 当前专利权人地址: US CA Carlsbad
- 主分类号: C12P17/10
- IPC分类号: C12P17/10 ; C12N1/16 ; C12N15/81 ; C12N9/10 ; C12N9/88 ; C12N9/12 ; C12N9/02
摘要:
The systems and methods herein include engineering a host to produce psilocybin using engineered enzymes, genetic changes, and exogenous psilocybin precursor addition (e.g., addition of L-tryptophan to a growing culture of a psilocybin producing recombinant host strain). The process occurs in genetically engineered host cell(s) that can produce psilocybin.
信息查询